GlucaGen

DRUG7 trials

Sponsors

Hospira, now a wholly owned subsidiary of Pfizer, Zealand Pharma, Steno Diabetes Center Copenhagen, Inreda Diabetic B.V.

Conditions

Diabetes Mellitus, Type 1HypoglycemiaType 1 Diabetes

Phase 1

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers

CompletedNCT00745186

Hospira, now a wholly owned subsidiary of PfizerHypoglycemia

Start: 2007-08-31End: 2008-03-31Updated: 2017-03-20

Phase 2

Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon

CompletedNCT02660008

Zealand PharmaHypoglycemia

Start: 2016-01-31End: 2016-06-30Updated: 2016-06-15

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System

WithdrawnNCT05454709

Inreda Diabetic B.V.Diabetes Mellitus, Type 1

Start: 2023-12-29End: 2023-12-29Updated: 2024-01-03

Phase 3

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

CompletedNCT03216226

Zealand PharmaDiabetes Mellitus, Type 1, Hypoglycemia

Start: 2017-06-28End: 2018-02-13Updated: 2021-05-04

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

CompletedNCT03378635

Zealand PharmaDiabetes Mellitus, Type 1, Hypoglycemia

Start: 2017-12-07End: 2018-05-25Updated: 2021-06-10

Unknown Phase

Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes

CompletedNCT05076292

Steno Diabetes Center CopenhagenHypoglycemia, Type 1 Diabetes

Start: 2021-11-23End: 2023-08-08Updated: 2023-12-05

Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes

CompletedNCT05379686

Steno Diabetes Center CopenhagenHypoglycemia, Type 1 Diabetes

Start: 2022-09-21End: 2024-05-13Updated: 2025-08-29

Related Papers

1053-P: Dasiglucagon Hypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial

Diabetes2020-06-014 citations